
---
title: '科兴制药：获得人干扰素α2b泡腾胶囊注册申请受理'
categories: 
 - 新媒体
 - 36kr
 - 快讯
headimg: 'https://picsum.photos/400/300?random=9287'
author: 36kr
comments: false
date: Mon, 20 Jun 2022 11:03:16 GMT
thumbnail: 'https://picsum.photos/400/300?random=9287'
---

<div>   
36氪获悉，科兴制药公告称，获得人干扰素α2b 阴道泡腾胶囊注册申请受理。该产品拟用于治疗病毒引起的宫颈炎，伴或不伴有阴道炎。  
</div>
            